Skip to main content

Complications of Ovulation Induction

  • Chapter
Office-Based Infertility Practice

Conclusions

There are numerous possible complications associated with the use of ovulation induction agents. As more and more women are undergoing superovulation, it is important to be well informed of these risks so we may adequately counsel our patients, take steps to minimize these risks, and know how to manage such complications when they occur.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

Suggested Reading

  • Antsaklis AJ, Drakakis P, Vlazakis GP, et al. Reduction of multifetal pregnancies to twins does not increase obstetric or perinatal risks. Hum Reprod 1999;14:1338–1340.

    Article  CAS  PubMed  Google Scholar 

  • ASRM Practice Committee Report. Guidelines on Number of Embryos Transferred, November 1999.

    Google Scholar 

  • ASRM Practice Committee Report. Multiple Pregnancy Associated with Infertility Therapy, November 2000.

    Google Scholar 

  • Bohrer M, Kemmann E. Risk factors for spontaneous abortion in menotropin-treated women. Fertil Steril 1987;48:571–575.

    CAS  PubMed  Google Scholar 

  • Bristow RE, Karlan BY. Ovulation induction, infertility, and ovarian cancer risk. Fertil Steril 1996;66:499–507.

    CAS  PubMed  Google Scholar 

  • Bristow RE, Karlan BY. The risk of ovarian cancer after treatment for infertility. Curr Opin Obstet Gynecol 1996;8:32–37.

    CAS  PubMed  Google Scholar 

  • Fisch JD, Milki AA, Behr B. Sibling embryo blastocyst development correlates with the in vitro fertilization day 3 embryo transfer pregnancy rate in patients under age 40. Fertil Steril 1999;71:750–752.

    CAS  PubMed  Google Scholar 

  • Fluker MR, Copeland JE, Yuzpe AA. An ounce of prevention: outpatient management of the ovarian hyperstimulation syndrome. Fertil Steril 2000;73:821–824.

    Article  CAS  PubMed  Google Scholar 

  • Gross TP, Schlesselman JJ. The estimated effect of oral contraceptive use on the cumulative risk of epithelia ovarian cancer. Obstet Gynecol vol. 83 p. 619–626, 1996.

    Google Scholar 

  • Haning RV Jr, Canick JA, Goldsmith LT, et al. The effect of ovulation induction on the concentration of maternal serum relaxin in twin pregnancies. Am J Obstet Gynecol 1996;174:227–232.

    CAS  PubMed  Google Scholar 

  • Hartge P, Schiffman MH, Hoover R, et al. A case control study of epithelial ovarian cancer. Am J Obstet Gynecol 1989;161:10–16.

    CAS  PubMed  Google Scholar 

  • Helzlsouer KJ, Alberg AJ, Gordon GB, et al. Serum gonadotropins and steroid hormones and the development of ovarian cancer. JAMA 1995;274:1926–1930.

    Article  CAS  PubMed  Google Scholar 

  • Hock DL, Seifer DB. Ovarian hyperstimulation syndrome. Infertil Reprod Med Clin North Am 2000;11:399.

    Google Scholar 

  • Houmard BS, Seifer DB. Infertility treatment and informed consent: current practices of reproductive endocrinologists. Obstet Gynecol 1999;93:252–257.

    Article  CAS  PubMed  Google Scholar 

  • Krasnow JS, Berga SL, Guzick DS, Zeleznik AJ, Yeo K-T. Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report. Fertil Steril 1996;65:552–555.

    CAS  PubMed  Google Scholar 

  • Lyons CA, Wheeler CA, Frishman GN, et al. Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors. Hum Reprod 1994;9:792–799.

    CAS  PubMed  Google Scholar 

  • Mathur RS, Akande AV, Keay SD, et al. Distinction between early and late ovarian hyperstimulation syndrome. Fertil Steril 2000;73:901–907.

    CAS  PubMed  Google Scholar 

  • McElhinney B, McClure N. Ovarian hyperstimulation syndrome. Baillieres Best Pract Res Clin Obstet Gynaecol 2000;14:103–122.

    Article  CAS  PubMed  Google Scholar 

  • Ron EL, Lunenfeld B, Menczer J, et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol 1987;125:780–790.

    CAS  PubMed  Google Scholar 

  • Rossing MA, Daling JR, Weiss NS, et al. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994;331:771–776.

    Article  CAS  PubMed  Google Scholar 

  • Schenker, et al. Complications of assisted reproductive techniques. Fertil Steril 1994;61:411–422.

    CAS  PubMed  Google Scholar 

  • Schildkraut JM, Schwingl PJ, Bastos E, Evanoff A, Hughes C. Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet Gynecol 1996;88:554–559.

    Article  CAS  PubMed  Google Scholar 

  • Sherwood OD. Relaxin. In: Knobil E, Neill (eds) The Physiology of Reproduction. New York: Raven, 1988:585–673.

    Google Scholar 

  • Shu XO, Brinton LA, et al. Population-based case-control study of ovarian cancer in Shanghai. Cancer Res 1989;49:3670–3674.

    CAS  PubMed  Google Scholar 

  • Spirtas R, Kaufman SC, Alexander NJ. Fertility drugs and ovarian cancer: red alert or red herring? Fertil Steril 1993;59:291–293.

    CAS  PubMed  Google Scholar 

  • Strandell A, Thorburn J, Hamberger L. Risk factors for ectopic pregnancy in assisted reproduction. Fertil Steril 1999;71:282–286.

    Article  CAS  PubMed  Google Scholar 

  • Tal J, Haddad S, Gordon N, Timor-Tritsch I. Heterotopic pregnancy after ovulation induction and assisted reproductive technologies: a literature review from 1971 to 1993. Fertil Steril 1996;66:1–12.

    CAS  PubMed  Google Scholar 

  • Venn A, Watson L, Lumley J, et al. Breast and ovarian cancer incidence after infertility and in vitro fertilization. Lancet 1995;346:995–1000.

    Article  CAS  PubMed  Google Scholar 

  • Weiss G, Goldsmith LT, Sachdev R, et al. Elevated first-trimester serum relaxin concentrations in pregnant women following ovarian stimulation predict prematurity and preterm delivery. Obstet Gynecol 1993;82:821–828.

    CAS  PubMed  Google Scholar 

  • Whelan J III, Vlahos N. The ovarian hyperstimulation syndrome. Fertil Steril 2000;73:883.

    Article  PubMed  Google Scholar 

  • Whittemore AS, Harris R, Itnyre J, et al. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. Part II. Am J Epidemiol 1992;136:1184–1203.

    CAS  PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Fonslick, J.A., Seifer, D.B. (2002). Complications of Ovulation Induction. In: Seifer, D.B., Collins, R.L. (eds) Office-Based Infertility Practice. Springer, New York, NY. https://doi.org/10.1007/0-387-21716-9_19

Download citation

  • DOI: https://doi.org/10.1007/0-387-21716-9_19

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-98390-5

  • Online ISBN: 978-0-387-21716-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics